Swiss eyecare firm Alcon has made a move to boost its position in ophthalmological medicines with a $15.25 per share offer to buy Aerie Pharmaceuticals in a transaction that values the US company ...

Alcon ALC has been gaining from a strong pipeline ... and Rhopressa and concluded Phase 3 trials for AR-15512, the dry-eye ...

Alcon Inc.’s ALC growth is driven by its ... 20.8% growth and the S&P 500 composite’s 31.2% increase. The renowned pharmaceutical and medical device manufacturer has a market capitalization ...

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and ...

Medical device peers Alcon, Cooper Cos. and Johnson & Johnson own 25% to 40% of the market for contact lenses vs. 10% for Bausch + Lomb. In pharmaceuticals, AbbVie would encounter antitrust ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The eye-care company Alcon Research has entered into licensing and purchase option agreements with Potentia Pharmaceuticals to develop Potentia's leading drug candidate — a complement pathway ...

The main portion of employees (over 60,000) worked in pharmaceuticals – the company's main focus – while the rest are split between Alcon, Sandoz, Vaccines and Diagnostics, Consumer Health ...

Novartis has also sold off its eye wear business, Alcon; exited its stake in pharma giant Roche for over $20 billion, and spun off its generic medicine arm Sandoz in 2023. But Novartis isn’t the ...

In a report released on October 10, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...